A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density

ConclusionWe conclude that metformin intervention resulted in favorable changes in anthropometric measures of adiposity and a borderline decrease in non-dense breast volume in women with metabolic dysregulation. More research is needed to understand the impact of metformin on breast cancer risk reduction.Trial registrationClinicalTrials.gov NCT02028221. Registered January 7, 2014,https://clinicaltrials.gov/ct2/show/NCT02028221
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research